{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:15:10Z","timestamp":1794852910879,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["No.2024MD764030"],"award-info":[{"award-number":["No.2024MD764030"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009976","name":"Chongqing Municipal Postdoctoral Science Special Foundation","doi-asserted-by":"publisher","award":["No. 2024COBSHTB3008"],"award-info":[{"award-number":["No. 2024COBSHTB3008"]}],"id":[{"id":"10.13039\/501100009976","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-05920-5","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:43:54Z","timestamp":1763135034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PROM2 exacerbates CCl4-Induced liver fibrosis via NLRP3 inflammasome activation and hepatocyte pyroptosis"],"prefix":"10.1007","volume":"82","author":[{"given":"Jiashi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8257-4468","authenticated-orcid":false,"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"5920_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101231","volume":"95","author":"M Parola","year":"2024","unstructured":"Parola M, Pinzani M (2024) Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies. Mol Aspects Med 95:101231","journal-title":"Mol Aspects Med"},{"issue":"3","key":"5920_CR2","first-page":"151","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D (2021) Molecular and cellular mechanisms of liver fibrosis and its regression, nature reviews. Gastroenterol Hepatol 18(3):151\u2013166","journal-title":"Gastroenterol Hepatol"},{"issue":"7","key":"5920_CR3","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","volume":"36","author":"P Horn","year":"2024","unstructured":"Horn P, Tacke F (2024) Metabolic reprogramming in liver fibrosis. Cell Metab 36(7):1439\u20131455","journal-title":"Cell Metab"},{"issue":"10308","key":"5920_CR4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N (2021) Kamath, liver cirrhosis. Lancet 398(10308):1359\u20131376","journal-title":"Lancet"},{"issue":"4","key":"5920_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/med.21948","volume":"43","author":"HL Ang","year":"2023","unstructured":"Ang HL, Mohan CD, Shanmugam MK, Leong HC, Makvandi P, Rangappa KS, Bishayee A, Kumar AP, Sethi G (2023) Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds. Med Res Rev 43(4):1141\u20131200","journal-title":"Med Res Rev"},{"issue":"3","key":"5920_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178\u201396","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"5920_CR7","first-page":"720","volume":"25","author":"KK Youssef","year":"2024","unstructured":"Youssef KK, Nieto MA (2024) Epithelial-mesenchymal transition in tissue repair and degeneration, nature reviews. Mol Cell Biol 25(9):720\u2013739","journal-title":"Mol Cell Biol"},{"key":"5920_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071587","author":"GD Marconi","year":"2021","unstructured":"Marconi GD, Fonticoli L, Rajan TS, Pierdomenico SD, Trubiani O, Pizzicannella J, Diomede F (2021) Epithelial-Mesenchymal transition (EMT): the type-2 EMT in wound healing, tissue regeneration and organ fibrosis. Cells. https:\/\/doi.org\/10.3390\/cells10071587","journal-title":"Cells"},{"issue":"1","key":"5920_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto M.A., Huang R.Y., Jackson R.A., Thiery J.P. (2016) EMT: 2016. Cell 166(1):21\u201345","journal-title":"Cell"},{"key":"5920_CR10","doi-asserted-by":"crossref","unstructured":"Lee JH, Massagu\u00e9 J (2022) TGF-\u03b2 in developmental and fibrogenic EMTs, seminars in cancer biology 86(Pt 2) 136\u2013145","DOI":"10.1016\/j.semcancer.2022.09.004"},{"issue":"3\u20134","key":"5920_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41417-019-0109-7","volume":"27","author":"SK Saha","year":"2020","unstructured":"Saha SK, Islam SMR, Kwak KS, Rahman MS, Cho SG (2020) PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis. Cancer Gene Ther 27(3\u20134):147\u2013167","journal-title":"Cancer Gene Ther"},{"key":"5920_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-4614-5894-4_2","volume":"777","author":"CA Fargeas","year":"2013","unstructured":"Fargeas CA (2013) Prominin-2 and other relatives of CD133. Adv Exp Med Biol 777:25\u201340","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"5920_CR13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.devcel.2019.11.004","volume":"51","author":"A Belavgeni","year":"2019","unstructured":"Belavgeni A, Bornstein SR, Linkermann A (2019) Prominin-2 suppresses ferroptosis sensitivity. Dev Cell 51(5):548\u2013549","journal-title":"Dev Cell"},{"issue":"3","key":"5920_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1632","volume":"14","author":"J Paris","year":"2024","unstructured":"Paris J, Wilhelm C, Lebb\u00e9 C, Elmallah M, Pamoukdjian F, H\u00e9raud A, Gapihan G, Walle AV, Tran VN, Hamdan D, Allayous C, Battistella M, Van Glabeke E, Lim KW, Leboeuf C, Roger S, Falgarone G, Phan AT, Bousquet G (2024) PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers. Clin Transl Med 14(3):e1632","journal-title":"Clin Transl Med"},{"key":"5920_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.freeradbiomed.2024.03.014","volume":"217","author":"T Wang","year":"2024","unstructured":"Wang T, Wang D, Kuang G, Gong X, Zhang L, Wan J, Li K (2024) Derlin-1 promotes diet-induced non-alcoholic fatty liver disease via increasing RIPK3-mediated necroptosis. Free Radic Biol Med 217:29\u201347","journal-title":"Free Radic Biol Med"},{"key":"5920_CR16","doi-asserted-by":"crossref","unstructured":"Muns JA, Schooten E, van Dasselaar RDJ, Noordman YE, Adamzek K, Eibergen AC, Pronk SD, Cali S, Sijbrandi NJ, Merkul E, Oliveira S, van Bergen En Henegouwen PMP, Takkenberg RB, Verheij J, van de Graaf SFJ, Nijmeijer BA, van Dongen G (2024) Preclinical targeting of liver fibrosis with a (89)Zr-labeled Fibrobody\u00ae directed against platelet derived growth factor receptor-\u03b2, European journal of nuclear medicine and molecular imaging.","DOI":"10.1007\/s00259-024-06785-9"},{"issue":"10","key":"5920_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F (2023) Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol 20(10):633\u2013646","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"5920_CR18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.tem.2016.06.004","volume":"27","author":"S Lovisa","year":"2016","unstructured":"Lovisa S, Zeisberg M, Kalluri R (2016) Partial epithelial-to-mesenchymal transition and other new mechanisms of kidney fibrosis. Trends Endocrinol Metab 27(10):681\u2013695","journal-title":"Trends Endocrinol Metab"},{"issue":"26","key":"5920_CR19","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3748\/wjg.v23.i26.4661","volume":"23","author":"S Munker","year":"2017","unstructured":"Munker S, Wu YL, Ding HG, Liebe R, Weng HL (2017) Can a fibrotic liver afford epithelial-mesenchymal transition? World J Gastroenterol 23(26):4661\u20134668","journal-title":"World J Gastroenterol"},{"key":"5920_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512412","author":"A Mottais","year":"2023","unstructured":"Mottais A, Riberi L, Falco A, Soccal S, Gohy S, De Rose V (2023) Epithelial-mesenchymal transition mechanisms in chronic airway diseases: a common process to target? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241512412","journal-title":"Int J Mol Sci"},{"key":"5920_CR21","doi-asserted-by":"publisher","first-page":"1258843","DOI":"10.3389\/fcell.2023.1258843","volume":"11","author":"DC Macias-Ceja","year":"2023","unstructured":"Macias-Ceja DC, Mendoza-Ballesteros MT, Ortega-Albiach M, Barrachina MD, Ortiz-Masi\u00e0 D (2023) Role of the epithelial barrier in intestinal fibrosis associated with inflammatory bowel disease: relevance of the epithelial-to mesenchymal transition. Front Cell Dev Biol 11:1258843","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"5920_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/08923973.2022.2128369","volume":"45","author":"B Zhang","year":"2023","unstructured":"Zhang B, Wu F, Li P, Li H (2023) ARRDC3 inhibits liver fibrosis and epithelial-to-mesenchymal transition via the ITGB4\/PI3K\/Akt signaling pathway. Immunopharmacol Immunotoxicol 45(2):160\u2013171","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"6","key":"5920_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","volume":"45","author":"NM Aiello","year":"2018","unstructured":"Aiello NM, Maddipati R, Norgard RJ, Balli D, Li J, Yuan S, Yamazoe T, Black T, Sahmoud A, Furth EE, Bar-Sagi D (2018) Stanger, EMT subtype influences epithelial plasticity and mode of cell migration. Dev Cell 45(6):681\u2013695e4","journal-title":"Dev Cell"},{"key":"5920_CR24","doi-asserted-by":"crossref","unstructured":"Usman S, Waseem NH, Nguyen TKN, Mohsin S, Jamal A, Teh MT, Waseem A (2021) Vimentin is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis. Cancers 13(19)","DOI":"10.3390\/cancers13194985"},{"issue":"11","key":"5920_CR25","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.2174\/138920111798377021","volume":"12","author":"MA Krasnapolski","year":"2011","unstructured":"Krasnapolski MA, Todaro LB, de Kier EB, Joff\u00e9 (2011) Is the epithelial-to-mesenchymal transition clinically relevant for the cancer patient? Curr Pharm Biotechnol 12(11):1891\u20131899","journal-title":"Curr Pharm Biotechnol"},{"issue":"18","key":"5920_CR26","first-page":"3312","volume":"125","author":"XF Xu","year":"2012","unstructured":"Xu XF, Dai HP (2012) Type 2 epithelial mesenchymal transition in vivo: truth or pitfalls? Chin Med J (Engl) 125(18):3312\u20133317","journal-title":"Chin Med J (Engl)"},{"key":"5920_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5010004","author":"AH Tennakoon","year":"2015","unstructured":"Tennakoon AH, Izawa T, Kuwamura M, Yamate J (2015) Pathogenesis of type 2 epithelial to mesenchymal transition (EMT) in renal and hepatic fibrosis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm5010004","journal-title":"J Clin Med"},{"issue":"19","key":"5920_CR28","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1016\/j.yexcr.2013.07.014","volume":"319","author":"NA Hosper","year":"2013","unstructured":"Hosper NA, van den Berg PP, de Rond S, Popa ER, Wilmer MJ, Masereeuw R, Bank RA (2013) Epithelial-to-mesenchymal transition in fibrosis: collagen type I expression is highly upregulated after EMT, but does not contribute to collagen deposition. Exp Cell Res 319(19):3000\u20133009","journal-title":"Exp Cell Res"},{"key":"5920_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28062652","author":"WA Batarfi","year":"2023","unstructured":"Batarfi WA, Mohd Yunus MH, Hamid AA (2023) The effect of Hydroxytyrosol in type II epithelial-mesenchymal transition in human skin wound healing. Molecules. https:\/\/doi.org\/10.3390\/molecules28062652","journal-title":"Molecules"},{"issue":"1","key":"5920_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03544-w","volume":"22","author":"J Li","year":"2024","unstructured":"Li J, Feng L, Yuan Y, He T, Zou X, Su B, Liu K, Yang X (2024) Inhibition of HOXC11 by Artesunate induces ferroptosis and suppresses ovarian cancer progression through transcriptional regulation of the PROM2\/PI3K\/AKT pathway. World J Surg Oncol 22(1):268","journal-title":"World J Surg Oncol"},{"issue":"1","key":"5920_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114190","volume":"442","author":"M Hu","year":"2024","unstructured":"Hu M, Yang J, Tan Z (2024) ATF1 promotes ferroptosis resistance in lung cancer through enhancing mRNA stability of PROM2. Exp Cell Res 442(1):114190","journal-title":"Exp Cell Res"},{"issue":"11","key":"5920_CR32","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/s41590-020-0783-5","volume":"21","author":"P Li","year":"2020","unstructured":"Li P, Lu M, Shi J, Gong Z, Hua L, Li Q, Lim B, Zhang XH, Chen X, Li S, Shultz LD, Ren G (2020) Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis. Nat Immunol 21(11):1444\u20131455","journal-title":"Nat Immunol"},{"issue":"11","key":"5920_CR33","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41419-021-04296-1","volume":"12","author":"W Luo","year":"2021","unstructured":"Luo W, Wang J, Xu W, Ma C, Wan F, Huang Y, Yao M, Zhang H, Qu Y, Ye D, Zhu Y (2021) LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer. Cell Death Dis 12(11):1043","journal-title":"Cell Death Dis"},{"issue":"8","key":"5920_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.198","volume":"10","author":"TT Nguyen","year":"2020","unstructured":"Nguyen TT, Gapihan G, Tetu P, Pamoukdjian F, El Bouchtaoui M, Leb\u0153uf C, Feugeas JP, Paris J, Baroudjian B, Delyon J, Mourah S, Lebb\u00e9 C, Janin A, Bousquet G, Battistella M (2020) Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes. Clin Transl Med 10(8):e198","journal-title":"Clin Transl Med"},{"issue":"4","key":"5920_CR35","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.62347\/EQFY1219","volume":"14","author":"KL Wu","year":"2024","unstructured":"Wu KL, Chang CY, Tsai YM, Lai JC, Hung JY, Lin YS, Tsai PH, Hsu YL (2024) PROM2 upregulation promotes cancer cell migration and confers a poor prognosis in lung squamous cell carcinoma. Am J Cancer Res 14(4):1561\u20131576","journal-title":"Am J Cancer Res"},{"issue":"1","key":"5920_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00473-5","volume":"7","author":"ZH Wu","year":"2021","unstructured":"Wu ZH, Tang Y, Yu H, Li HD (2021) The role of ferroptosis in breast cancer patients: a comprehensive analysis. Cell Death Discov 7(1):93","journal-title":"Cell Death Discov"},{"key":"5920_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16183180","author":"A Bustamante","year":"2024","unstructured":"Bustamante A, Baritaki S, Zaravinos A, Bonavida B (2024) Relationship of signaling pathways between RKIP expression and the inhibition of EMT-inducing transcription factors SNAIL1\/2, TWIST1\/2 and ZEB1\/2. Cancers. https:\/\/doi.org\/10.3390\/cancers16183180","journal-title":"Cancers"},{"key":"5920_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.rvsc.2020.04.007","volume":"131","author":"ES Veloso","year":"2020","unstructured":"Veloso ES, Gon\u00e7alves INN, Silveira TL, Espirito Santo JT, Figueiredo LV, Varaschin MS, Cassali GD, Del Puerto HL, Ferreira E (2020) ZEB and snail expression indicates epithelial-mesenchymal transition in canine melanoma. Res Vet Sci 131:7\u201314","journal-title":"Res Vet Sci"},{"issue":"1","key":"5920_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24734-0","volume":"12","author":"Y Koda","year":"2021","unstructured":"Koda Y, Teratani T, Chu PS, Hagihara Y, Mikami Y, Harada Y, Tsujikawa H, Miyamoto K, Suzuki T, Taniki N, Sujino T, Sakamoto M, Kanai T, Nakamoto N (2021) CD8(+) tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. Nat Commun 12(1):4474","journal-title":"Nat Commun"},{"issue":"12","key":"5920_CR40","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","volume":"15","author":"RF Schwabe","year":"2018","unstructured":"Schwabe RF, Luedde T (2018) Apoptosis and necroptosis in the liver: a matter of life and death. Nat Rev Gastroenterol Hepatol 15(12):738\u2013752","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"5920_CR41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","volume":"74","author":"S Gaul","year":"2021","unstructured":"Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, Wree A, Damm G, Seehofer D, Calvente CJ, Povero D, Kisseleva T, Eguchi A, McGeough MD, Hoffman HM, Pelegrin P, Laufs U, Feldstein AE (2021) Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol 74(1):156\u2013167","journal-title":"J Hepatol"},{"key":"5920_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106489","volume":"84","author":"A Al Mamun","year":"2020","unstructured":"Al Mamun A, Wu Y, Jia C, Munir F, Sathy KJ, Sarker T, Monalisa I, Zhou K, Xiao J (2020) Role of pyroptosis in liver diseases. Int Immunopharmacol 84:106489","journal-title":"Int Immunopharmacol"},{"key":"5920_CR43","doi-asserted-by":"crossref","unstructured":"Hurtado-Navarro L, Angosto-Bazarra D, Pelegr\u00edn P, Baroja-Mazo A, Cuevas S (2022) NLRP3 inflammasome and pyroptosis in liver pathophysiology: the emerging relevance of Nrf2 Inducers, antioxidants (Basel. Switzerland) 11(5)","DOI":"10.3390\/antiox11050870"},{"issue":"1","key":"5920_CR44","first-page":"556","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wu R, Zhan X, Wang XY, Xiang LW, Duan YQ, You Y, Zhang JB, Wu R, Zhang YY, Duan L (2024) Neutrophil extracellular traps facilitate liver inflammation\/fibrosis progression by entering macrophages and triggering AIM2 inflammasome-dependent pyroptosis, cell communication and signaling. CCS 22(1):556","journal-title":"CCS"},{"key":"5920_CR45","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000868","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Chen DP, Chen HD, Wang YZ, Shi W, Lu YT, Ren YZ, Wu YK, Pang YH, Deng H, He X, Kuang DM, Guo ZY (2024) NK-cell-elicited gasdermin-D-dependent hepatocyte pyroptosis induces neutrophil extracellular traps that facilitate HBV-related acute-on-chronic liver failure. Hepatology. https:\/\/doi.org\/10.1097\/HEP.0000000000000868","journal-title":"Hepatology"},{"key":"5920_CR46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","volume":"17","author":"M de Carvalho Ribeiro","year":"2022","unstructured":"de Carvalho Ribeiro M, Szabo G (2022) Role of the inflammasome in liver disease. Annu Rev Pathol 17:345\u2013365","journal-title":"Annu Rev Pathol"},{"key":"5920_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1279264","volume":"14","author":"D Xie","year":"2023","unstructured":"Xie D, Ouyang S (2023) The role and mechanisms of macrophage polarization and hepatocyte pyroptosis in acute liver failure. Front Immunol 14:1279264","journal-title":"Front Immunol"},{"key":"5920_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102691","volume":"62","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Zhao C, Tai Y, Li B, Lan T, Lai E, Dai W, Guo Y, Gan C, Kostallari E, Tang C, Gao J (2023) Sting mediates hepatocyte pyroptosis in liver fibrosis by epigenetically activating the NLRP3 inflammasome. Redox Biol 62:102691","journal-title":"Redox Biol"},{"issue":"3","key":"5920_CR49","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.26592","volume":"59","author":"A Wree","year":"2014","unstructured":"Wree A, Eguchi A, McGeough MD, Pena CA, Johnson CD, Canbay A, Hoffman HM, Feldstein AE (2014) Nlrp3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59(3):898\u2013910","journal-title":"Hepatology"},{"key":"5920_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109321","volume":"113","author":"Y Wan","year":"2022","unstructured":"Wan Y, Zhang W, Huang C, Jian J, Zhang Y, Liu Q, Chen P, Zhu X (2022) Ursolic acid alleviates Kupffer cells pyroptosis in liver fibrosis by the NOX2\/NLRP3 inflammasome signaling pathway. Int Immunopharmacol 113:109321","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"5920_CR51","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/jat.4258","volume":"42","author":"Y Qin","year":"2022","unstructured":"Qin Y, Gu T, Ling J, Luo J, Zhao J, Hu B, Hua L, Wan C, Jiang S (2022) PFOS facilitates liver inflammation and steatosis: an involvement of NLRP3 inflammasome-mediated hepatocyte pyroptosis. J Appl Toxicol 42(5):806\u2013817","journal-title":"J Appl Toxicol"},{"key":"5920_CR52","doi-asserted-by":"publisher","first-page":"780496","DOI":"10.3389\/fphar.2022.780496","volume":"13","author":"L Yu","year":"2022","unstructured":"Yu L, Hong W, Lu S, Li Y, Guan Y, Weng X, Feng Z (2022) The NLRP3 inflammasome in non-alcoholic fatty liver disease and steatohepatitis: therapeutic targets and treatment. Front Pharmacol 13:780496","journal-title":"Front Pharmacol"},{"issue":"5","key":"5920_CR53","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou GN, Masters SL, Schroder K, Cooper MA, Feldstein AE, Farrell GC (2017) NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 66(5):1037\u20131046","journal-title":"J Hepatol"},{"issue":"2","key":"5920_CR54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.gendis.2021.12.006","volume":"10","author":"HV Charan","year":"2023","unstructured":"Charan HV, Dwivedi DK, Khan S, Jena G (2023) Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: therapeutic potential for liver fibrosis. Genes Dis 10(2):480\u2013494","journal-title":"Genes Dis"},{"issue":"2","key":"5920_CR55","first-page":"191","volume":"12","author":"M Sun","year":"2024","unstructured":"Sun M, Zhang Y, Guo A, Xia Z, Peng L (2024) Progress in the correlation between inflammasome NLRP3 and liver fibrosis. J Clin Transl Hepatol 12(2):191\u2013200","journal-title":"J Clin Transl Hepatol"},{"key":"5920_CR56","doi-asserted-by":"publisher","first-page":"643149","DOI":"10.3389\/fimmu.2021.643149","volume":"12","author":"WJ Zhang","year":"2021","unstructured":"Zhang WJ, Chen SJ, Zhou SC, Wu SZ, Wang H (2021) Inflammasomes Fibros Front Immunol 12:643149","journal-title":"Inflammasomes Fibros Front Immunol"},{"key":"5920_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115861","volume":"217","author":"E Ramos-Tovar","year":"2023","unstructured":"Ramos-Tovar E, Muriel P (2023) Nlrp3 inflammasome in hepatic diseases: a pharmacological target. Biochem Pharmacol 217:115861","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"5920_CR58","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154446","volume":"23","author":"B Kaufmann","year":"2022","unstructured":"Kaufmann B, Leszczynska A, Reca A, Booshehri LM, Onyuru J, Tan Z, Wree A, Friess H, Hartmann D, Papouchado B, Broderick L, Hoffman HM, Croker BA, Zhu YP, Feldstein AE (2022) Nlrp3 activation in neutrophils induces lethal autoinflammation, liver inflammation, and fibrosis. EMBO Rep 23(11):e54446","journal-title":"EMBO Rep"},{"key":"5920_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7269150","volume":"2020","author":"Y Tao","year":"2020","unstructured":"Tao Y, Wang N, Qiu T, Sun X (2020) The role of autophagy and NLRP3 inflammasome in liver fibrosis. Biomed Res Int 2020:7269150","journal-title":"Biomed Res Int"},{"key":"5920_CR60","doi-asserted-by":"publisher","first-page":"154971","DOI":"10.1016\/j.phymed.2023.154971","volume":"118","author":"T Qin","year":"2023","unstructured":"Qin T, Hasnat M, Wang Z, Hassan HM, Zhou Y, Yuan Z, Zhang W (2023) Geniposide alleviated bile acid-associated NLRP3 inflammasome activation by regulating SIRT1\/FXR signaling in bile duct ligation-induced liver fibrosis. Phytomedicine 118:154971","journal-title":"Phytomedicine"},{"issue":"4","key":"5920_CR61","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jcmgh.2019.12.008","volume":"9","author":"SY Cai","year":"2020","unstructured":"Cai SY, Ge M, Mennone A, Hoque R, Ouyang X, Boyer JL (2020) Inflammasome is activated in the liver of cholestatic patients and aggravates hepatic injury in bile duct-ligated mouse. Cell Mol Gastroenterol Hepatol 9(4):679\u2013688","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"10","key":"5920_CR62","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1158\/2326-6066.CIR-20-1019","volume":"9","author":"L Fan","year":"2021","unstructured":"Fan L, Xu C, Ge Q, Lin Y, Wong CC, Qi Y, Ye B, Lian Q, Zhuo W, Si J, Chen S, Wang L (2021) Muciniphila suppresses colorectal tumorigenesis by inducing TLR2\/NLRP3-mediated M1-like TAMs. Cancer Immunol Res 9(10):1111\u20131124","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"5920_CR63","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/hep.32320","volume":"76","author":"DM Calcagno","year":"2022","unstructured":"Calcagno DM, Chu A, Gaul S, Taghdiri N, Toomu A, Leszczynska A, Kaufmann B, Papouchado B, Wree A, Geisler L, Hoffman HM, Feldstein AE, King KR (2022) NOD-like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH. Hepatology 76(3):727\u2013741","journal-title":"Hepatology"},{"issue":"2","key":"5920_CR64","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1124\/jpet.123.001639","volume":"386","author":"D Povero","year":"2023","unstructured":"Povero D, Lazic M, McBride C, Ambrus-Aikelin G, Stansfield R, Johnson CD, Santini AM, Pranadinata RF, McGeough MD, Stafford JA, Hoffman HM, Feldstein AE, Veal JM, Bain G (2023) Pharmacology of a potent and novel inhibitor of the NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome that attenuates development of nonalcoholic steatohepatitis and liver fibrosis. J Pharmacol Exp Ther 386(2):242\u2013258","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05920-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05920-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05920-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T19:07:04Z","timestamp":1763406424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05920-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5920"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05920-5","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors confrm their consent for publication the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study was conducted in accordance with the Decla-ration of Helsinki, and approved by the Medical Research Ethics Committee of The Second Affiliated Hospital of Chongqing Medical University (Date of approval February25,2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of competing interest"}}],"article-number":"403"}}